GlassScriptPhysician profile
Dallis Dillon
NPI 1689306326
$2,155.73
in general payments reported to CMS, 2019-2025
23 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $363 · 2023: $1,328 · 2024: $196 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,609.56 |
| Education | $182.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $566.92 | 2022-2025 | |
| Astellas Pharma US INC | $395.86 | 2022-2023 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $214.88 | 2022-2025 | Tremfya, Erleada |
| Sumitomo Pharma America, INC. | $182.41 | 2023 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $144.12 | 2022-2023 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $83.48 | 2022-2023 | Lynparza |
| Pfizer INC. | $80.28 | 2022-2023 | |
| Axonics, INC. | $69.07 | 2023 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $67.12 | 2022-2023 | Lynparza, Keytruda, Welireg |
| Convatec INC. | $52.79 | 2023 | |
| Urovant Sciences INC | $31.96 | 2022 | |
| Myovant Sciences INC. | $31.80 | 2022 | |
| Lilly USA, LLC | $29.22 | 2025 | Taltz, Ebglyss |
| Genzyme Corporation | $28.83 | 2024 | |
| Olympus America INC. | $24.51 | 2023 | Itind System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.26 | 2025 | Sotyktu |
| Tolmar, INC. | $22.40 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $19.88 | 2022 | |
| Procept Biorobotics Corporation | $19.58 | 2022 | |
| Organon LLC | $19.00 | 2025 | Vtama |
| Alnylam Pharmaceuticals INC. | $16.56 | 2023 | Oxlumo |
| Amgen INC. | $16.38 | 2025 | Otezla |
| Incyte Corporation | $15.42 | 2025 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dallis Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.